Salt Lake City, UT (PRWEB) June 30, 2014
Dr. Brent Satterfield, CTO of Co-Diagnostics Inc., will be featured in the upcoming 4th Advanced TB Diagnostic Research Course in Quebec, Canada on July 7-11, 2014.
Dr. Satterfield will participate as an industry expert in a panel discussing the gaps in the tuberculosis testing product pipeline and if industry is able to fill in those gaps. Later, he will also be presenting Co-Diagnostics tuberculosis products currently in development and soon to be deployed by Co-Diagnostics HBDC in India.
Co-Diagnostics CEO Dwight Egan commented, “The participants appearing at the course include representatives from some of the most respected and noted research facilities and philanthropic organizations throughout the world, and we are honored that Dr. Satterfield will have a venue to present our technology and approach to such esteemed company. We are confident that he will be well-received, and we look forward to the awareness that will come from this global health market opportunity.”
Co-Diagnostics, Inc., a molecular diagnostics company, is a Utah corporation based in Sandy, Utah that develops, manufactures and markets fully integrated DNA test systems. The company’s intellectual property is based on mathematical principles that create algorithms in a unique DNA-based diagnostics system that is superior in cost and speed of development to all other such systems, both in the US and abroad.